86
Participants
Start Date
May 19, 2022
Primary Completion Date
May 26, 2025
Study Completion Date
May 26, 2025
STN1010904 ophthalmic suspension 0.03% BID
0.03% STN1010904 ophthalmic suspension BID
STN1010904 ophthalmic suspension 0.1% BID
0.1% STN1010904 ophthalmic suspension BID
Placebo (Vehicle) BID
Placebo (vehicle) BID
UPMC, Pittsburgh
Scott Christie and Associates, Cranberry Township
Johns Hopkins University, Baltimore
University Hospital of Saint-Etienne, Saint-Etienne
Price Vision Group, Indianapolis
Mayo Clinic, Rochester
Comprehensive Eye Care, Ltd, Washington
Tauber Eye Center, Kansas City
Fondation Ophtalmologique Adolphe de Rothschild, Paris
Stein Eye Institution UCLA, Los Angeles
Devers Eye Institute, Portland
Suven Clinical Research CenterL V Prasad Eye Institute, Banjara Hills
Metropolitan Eye Research and Surgery Center, Palisades Park
Houston Eye Associates, Houston
Medical Research Foundation, Chennai
ActualEyes Inc.
UNKNOWN
Santen Inc.
INDUSTRY